To include your compound in the COVID-19 Resource Center, submit it here.

MX8899 histamine dihydrochloride: Phase I/II

MAXM started a blinded Israeli Phase I/II trial of MX8899

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE